Related Experiment Videos
Endomorphins and related opioid peptides
Yoshio Okada1, Yuko Tsuda, Sharon D Bryant
1Faculty of Pharmaceutical Sciences, High Technology Research Center, Kobe Gakuin University, Kobe 651-2180, Japan.
Vitamins and Hormones
|December 17, 2002
Summary
Endomorphins, potent opioid peptides, selectively target mu-opioid receptors, offering potential for novel pain relief with reduced side effects. Their unique structure may lead to new analgesic drugs.
Area of Science:
- Neuroscience
- Pharmacology
- Biochemistry
Background:
- Opioid peptides and their receptors (delta, kappa, mu) are crucial for pain modulation in the central nervous system and peripheral tissues.
- Research aims to understand pain mechanisms and develop effective analgesics with low abuse potential and side effects.
Purpose of the Study:
- To investigate the properties of endomorphins-1 and -2, novel endogenous opioid peptides.
- To explore their potential for developing new pain-control therapeutics.
Main Methods:
- Isolation and characterization of endomorphins-1 and -2 from bovine and human brain tissue.
- Assessment of their binding affinity and selectivity for mu, delta, and kappa opioid receptors.
Main Results:
- Endomorphin-1 and endomorphin-2 exhibit high affinity and remarkable selectivity for mu-opioid receptors.
- These peptides activate G-proteins, influencing gastrointestinal motility, antinociception, vascular systems, and memory.
Conclusions:
- Endomorphins represent promising candidates for developing novel analgesics with improved safety profiles.
- Structure-activity relationship studies of endomorphins can lead to more potent and stable pain-management drugs.